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Abstract 
Background: Power, socioeconomic inequalities, and poverty are recognized as some of the 
fundamental determinants of differences in vulnerability of societies to infectious disease 
threats. The economic south is carrying a higher burden than those in the economic north. 
This raises questions about whether social preventions and biomedical preventions for 
infectious disease are given equal consideration, and about social institutions and structures 
that frame the debate about infectious disease. 
This article examines how institutionalized ways of talking about infectious disease 
reinforces, creates, and sustains health inequalities. 
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Methodology: Critical discourse analysis was considered to be epistemologically and 
ontologically consistent with the aims and context of this study. 
Results: The study examined three types of infectious disease: 
• Emerging infectious diseases/pathogens 
• Neglected tropical diseases 
• Vector-borne infections. 
Examination revealed that poverty is the most common determinant of all three. 
Conclusion: A sustainable reduction in infectious disease in the southern countries is most 
likely to be achieved through tackling socioeconomic determinants. There is a need for a 
change in the discourse on infectious disease, and adopt a discourse that promotes self-
determination, rather than one that reinforces the hero-victim scenario and power inequalities. 
Keyword: Critical discourse, inequalities, infectious disease, poverty, power 
<H1>Background 
Power, socioeconomic inequalities, and poverty are recognized as some of the fundamental 
determinants of differences in the vulnerability of societies to infectious disease threats.[1-7] 
These differences in the burden of infectious disease have been observed between countries 
in the economic north and south: countries in the economic south have a higher burden of 
infectious disease.[5,7-9] Despite this evidence, the strategies to prevent, eliminate, and control 
infectious disease continue to focus exclusively on biomedical interventions through drug 
administration.[6,7,9] This raises questions about whether the social and biomedical 
explanations of infectious disease are given equal consideration and about social institutions 
and structures that frame the debate. 
This paper uses a critical discourse analysis (CDA) approach to examine how the language 
used to conceptualize infectious diseases produces unequal power relations between societies 
3 
 
that suffer endemic infectious disease and those who benefit from its decline.[10] In this paper, 
“critical discourse analysis” refers to a: 
…methodological approach to language and society that centers on discourse as 
social practice: [and] uses micro-level analysis of discourse (words, phrases, 
conceptual metaphors) to uncover the processes by which ideology of power abuse, 
control, dominance, exclusion, injustice and inequity are created, re-created, and 
perpetuated in social life-processes which are often “naturalised” and taken for 
granted as common-sense notions [8, pp.312-313]. 
CDA advocates that researchers should be transparent about the particular philosophical 
position, values, and beliefs that make up the critical stance of their work.[11-13] Consistent 
with this, the authors declare that the ontological position taken in this paper is based upon a 
belief in social justice being a foundation principle for public health, and also that public 
health is a strategy to reduce social and health inequalities.[11,14-16] The authors theorize that 
discursive practices produce unequal power and control within the arena of infectious disease 
management, as those with vested interests set the discursive context.[11] 
The impetus for pursuing this line of argument comes from evidence that indicates the 
decline in mortality has been steeper in countries in the economic north than in the economic 
south.[8] We argue that this uneven distribution has created a metaphorical scenario of 
“heroes” and “victims,” whereby northern countries which have benefited from the decline 
increasingly assume a heroic status, lending a hand to the southern victims who need the 
burden of infectious disease to be lifted off them. This hero-victim scenario is signified by the 
amount of investment by northern-based international organizations to tackle infectious 
disease in southern, and particularly African, countries. Ayittey[17] indicates that the discourse 
reality of southern Africa in the eyes of international investors and support agencies is 
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characterized by terms such as civil unrest, starvation, deadly diseases, and economic 
disorder [17, p.6]. The populations of southern countries have become victims of the 
discourse, which portrays them to the world as being less worthy than their northern 
counterparts owing to factors beyond their control. The normalization of language such as 
“deadly diseases” creates an understanding that southern countries are victims of infectious 
disease, poverty, unrest, and so on, which embeds the inverse care paradox.[17,18] 
The discourse commonly used to conceptualize infectious disease includes phrases such as 
“new,” “old,” “emerging,” “re-emerging,” “the neglected tropical diseases (NTDs),” “vector-
borne infectious diseases (VBIs),” and “infectious diseases of poverty,” which reinforces the 
hero-victim scenario and regulates action and inaction, thereby exerting power.[11] Jäger and 
Maier[11] describe this as “institutionalized talking”: the use of language to manage practical 
tasks and to perform the particular activities associated with participation in an institutional 
context. Arguably, these create an understanding of infectious disease management, which 
signifies the limitations of biomedical interventions to tackle the root causes of vulnerability 
and susceptibility to infectious disease. While biotechnological advances—particularly 
improvements in surveillance, early detection, vaccination, and antimicrobial drugs—have 
reduced infectious disease mortality rates,[19] the long-term sustainability of these measures is 
questionable, particularly in southern countries due to the transient nature of infectious 
diseases: as soon as we discover solutions to existing diseases, new ones take their place 
because the fundamental causes remain in place.[20-25] 
The enduring advances in the health of people have come from improvements in social and 
economic status, including access to basic and essential resources such as clean air, better 
housing, potable water, sanitation, and nutritious food.[26,27] The fact that mortality from 
infectious disease is highest in populations in the economic south[23,25] implies that power 
inequalities and poverty create conditions that enable infectious diseases to thrive and prevent 
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subsequent access to healthcare.[28] This position is based on evidence from several 
epidemiological studies that consistently demonstrate decreases in morbidity and mortality 
correlating with increases in socioeconomic position.[24,25,28-30] 
The Global Report for Research on Infectious Diseases of Poverty produced by the World 
Health Organization (WHO) in 2012[28] explains that social, economic, and biological factors 
interact to drive a vicious cycle—the occurrence, distribution, emergence, and re-emergence of 
poverty and infectious disease.[25,30] The report explains that even where effective interventions 
to treat infectious disease are available, the environments in which poor people live are often 
conducive to its emergence, re-emergence, and spread.[28] Furthermore, social forces 
including globalization, environmental degradation, international trade, migration, conflicts, 
and terrorist threats have shaped the definition and contours of infectious disease, and the 
rapidity with which it changes.[7,9,31] 
<H1>Methodology 
This article aims to examine how institutionalized ways of talking about infectious disease 
reinforce the hero-victim scenario and create and sustain health inequalities. 
CDA was considered to be epistemologically and ontologically consistent with the aims and 
context of this study,[22,23] in that it primarily considers the way power inequalities and 
dominance are enacted, reproduced, and resisted by text and talk in social and political 
contexts.[32,33] Thus, CDA is sympathetic to the key argument that health inequalities are 
fundamental causes of differences in the distribution of morbidity and mortality from 
infectious disease.[34-36] In our critique, we are mindful of Popper’s[37] warnings about the 
limitations of prevailing scientific paradigms, and of Polyani’s[38] guidance about our tacit 
understandings and non-detached construction of personal and scientific knowledge.[38,39] 
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The principle underpinning critical discourse research is its commitment to identifying and 
challenging unjust social structures, policies, beliefs, and practices [19, p.60]. It affirms/holds 
the belief that inequalities in health are the outcome of material, power, social, and cultural 
inequalities across societies, which are, in turn, the product of inequalities in power, income, 
wealth, knowledge, social status, and social connections.[15,32,33,36,40,41] 
This article argues that the language used to construct the discourse of infectious diseases 
signifies how their occurrence and distribution are created and sustained by power 
inequalities. CDA allows greater insight into how language can be used by those with a 
privileged social position to determine what constitutes valid and reliable knowledge.[22,23] 
For example, decisions about interventions to tackle infectious diseases are constructed 
through such concepts as “reliable” and “valid” and “evidence-based knowledge.” The 
knowledge constructed in these terms is perceived as sacred and immune to value-judgement. 
CDA research accepts that the construct of evidence-based knowledge derives from the social 
context and is interpreted through discursive constructs in a language which is influenced by 
sociocultural factors.[29] In this way, CDA recognizes that what is considered to be scientific 
knowledge is inherently part of and influenced by social structures, and produced in social 
interaction. Therefore, it enables researchers to examine how these constructs can be used by 
communities of knowledge that seek to disadvantage certain groups and positions, or do so 
inadvertently. 
<H1>Description of Materials and Analysis 
 
We initially consulted and read many websites, looking for themes that demonstrate how 
institutionalized ways of talking about infectious disease regulate, reinforce, and shape 
action, and thereby exert power. We then limited our analysis to themes emerging from three 
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major international organizations that influence policy on infectious disease: World Health 
Organization (WHO), National Institute for Allergy and Infectious Diseases (NIAID), and 
Centers for Disease Control (CDC). The following themes emerged from these key websites: 
• Emerging infectious diseases (EIDs)/pathogens 
• Neglected tropical diseases 
• Vector-borne infections. 
A literature review was undertaken to examine how infectious disease discourse is 
represented in the literature, guided by Bacchi’s[42] analytical questions: 
(1) What is the problem of infectious disease represented to be? 
(2) What assumptions underlie this representation of the discourse on infectious disease? 
(3) How has this representation of the problem come about? 
(4) What are the gaps and silences? 
(5) What effects are produced by this representation of the problem? 
(6) How and where have these representations been produced and disseminated? 
 
Rather than slavishly follow Bacchi’s[42] questions, we took a holistic approach and 
integrated them in various aspects of this article where we deemed appropriate. For example, 
the first, second, and fourth questions formed an integral part of the background and 
presentation of findings sections of this paper. The third question was excluded as it would 
have required extensive policy analysis which is beyond the scope of this article. The fifth 
and sixth questions were integrated in the discussion section of this paper. The authors 
acknowledge that extensive exploration of all six questions was not possible due to the limit 
on how much one can fit in one article. 
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<H1>Findings: The Assumptions which Underlie this Representation of Infectious 
Disease 
The use of the Bacchi’s[42] framework enabled us to uncover what we believe is being taken 
for granted about the institutionalized ways of talking about infectious disease. We 
acknowledge this represents our perspective of discourse, which is informed by our 
experiences, values, and beliefs in our context and time. The assertion by Wodak and 
Meyer[43] resonates with our experiences in relation to the discourse on infectious disease: 
that it is easy to assume that we have solved the problem by discovering things. They go on 
to explain that the more we write about these things, the more we take their existence for 
granted. Bacchi[42] makes a similar observation in policymaking contexts, that the common 
assumption by policymakers is that policies solve social problems, but contends that although 
policies give shape to the problem, they do not necessarily address it.[37] This is true for the 
institutions of power in infectious disease: they appear to assume that by grouping infectious 
disease in different categories, they found common solutions to all those belonging to the 
same category. They then assume that by framing their assumption in terms of evidence-
based practice/guidelines, they can purport political and ideological neutrality. This discourse 
separates illness from the context within which it occurs. For example, WHO[44] published 
the comprehensive Practical Guidelines for Infection Control in Health Care Facilities in 
2004, and in 2016 published Guidelines on Core Components of Infection Prevention and 
Control Programmes at the National and Acute Health Care Facility Level.[45] The WHO[45] 
states as its two objectives: 
…to provide evidence-based recommendations on the core components of IPC 
[infection prevention and control] programmes that are required to be in place at the 
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national and acute facility level to prevent hospital-acquired infections (HAI) through 
IPC good practices; 
…to support countries and health care facilities to develop or strengthen IPC 
programmes and strategies through the provision of evidence- and consensus-based 
guidance that can be adapted to the local context, while taking account of available 
resources and public health needs. 
These are just two examples, but there many similar examples where the dominant powers 
assume that by producing policies and guidelines, and validating them in terms of problem 
solving and evidence-based discourse, they have solved the problem, when in actual fact they 
shifted the focus of discourse from its social context, thus constructing it as politically 
neutral. The unintended consequences of this approach are reinforcing power inequalities and 
creating hero-victim status, thus generating an inverse care law effect.[18] CDA advocates a 
paradigm shift from problem solving to problem questioning, thereby uncovering the 
discursive processes through which infectious disease discourse is shaped and communicated, 
normalized and propagated, which involve hidden dimensions of power, control, and 
inequality.[42,43] 
<H2>Emerging infectious diseases/pathogens 
Emerging and re-emerging infectious diseases are commonly defined, respectively, as 
diseases/pathogens that are recognized in a human host for the first time; and diseases that 
historically have infected humans, but continue to appear in new locations or in drug-resistant 
forms, or that reappear after apparent control or elimination.[46,47] The concept of EIDs is 
closely related to the discourse of risk management.[48] As such, EIDs are conceptualized 
within the positivist paradigm and scientific solutions are given credence. The focus on risk 
emerges as the accepted discourse, to the detriment of other discourses. Attention is directed 
10 
 
toward the organic causes of disease, which can be studied and addressed by downstream 
biomedical interventions.[48,49] This allows control of the agenda for infectious disease to rest 
with those who benefit from downstream interventions.[48] Dissenting discourses appear 
abnormal as they infringe upon the rules of the discursive regime created by the scientific 
community.[50] The outcome is that socioeconomic or upstream interventions are considered 
secondary.[49,50] 
The WHO[51] published a list of the top eight EIDs needing urgent research and development 
(R&D) attention [Table 1]. In addition, the WHO designated chikungunya, severe fever with 
thrombocytopenia syndrome, and Zika as serious EIDs that require urgent action by their 
R&D staff.[51] The WHO’s list reflects those of several other international agencies such as 
the CDC[52] and NIAID.[47] Four out of eight diseases listed by WHO also appear on the 
NIAID list of category A priority pathogens, organisms/biological agents that pose the 
highest risk to national security and public health. A further three EIDs on the WHO priority 
list—coronavirus diseases, chikungunya, and Nipah and Rift Valley fever—also appear on 
the NIAID list of category C priority pathogens, their third highest priority. 
For this paper, the global distribution of these EIDs and how the priority was decided are 
significant. It has been observed that the highest prevalence of the majority of them is in 
countries in the economic south, which are already battling with other adverse social, 
economic, and political conditions [see Table 3]. 
The evidence shows that in the last three decades approximately one to three new human 
infectious diseases have been identified each year; others have re-emerged, causing greater 
numbers of cases than before or affecting different populations and regions than in the past 
(e.g., dengue fever or Ebola), while others have developed resistance to available treatments 
(e.g., multi-drug resistant tuberculosis).[30,53] 
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A number of factors contribute to disease emergence, including population growth and 
movement, changes in land use, greater contact between people and animals, international 
travel and trade, and poor public health infrastructure. EIDs that have attracted global 
attention or responses over the last few decades include HIV, SARS, H1N1, H5N1, and 
Ebola.[53] The recent outbreaks of Ebola in West Africa, and persistent malaria, tuberculosis 
(TB), HIV/AIDS, and other infectious diseases in low-income countries, are an indication 
that these conditions cluster and persist wherever poverty is widespread.[30,54] 
Most re-emerging infectious diseases, including dengue virus, West Nile virus, cholera, 
multi-drug resistant tuberculosis, and drug-resistant malaria,[30] are endemic in low-income 
countries. The few re-emerging infectious diseases that commonly occur in the developed 
world, including MRSA and C. Diff, are often associated with excessive or inappropriate use 
of antibiotics.[30] 
<H2>Neglected tropical diseases 
The scientific rationale for grouping these infectious agents as NTDs began in the years 
following the release of the United Nations’ millennium development goals (MDGs), and 
emerged through key WHO meetings held in Geneva and Berlin. The WHO’s Global 
Report[28] produced a list of infectious diseases that are considered “neglected tropical 
diseases” [Table 2]: 
The report indicates that though these are not restricted to low-income countries, they 
manifest more in poor populations globally.[28,29] Molyneux[29] and several others reported 
that large numbers of the world’s poorest people remain afflicted or are at risk from this 
group of diseases, and yet none of the international agencies have given them priority. 
Hotez[55] argues that the concept of NTDs is associated with the reproduction of colonial 
attitudes toward tropical countries; the phrase indicates that science diplomacy is seen by the 
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western powers as the best mechanism for health advocacy within tropical countries.[55] Here 
the premise that western science is the only mechanism to resolve these issues is spoken into 
existence and becomes the dominant discourse. Socioeconomic and cultural solutions are 
disparaged.[55] 
Furthermore, the notion of neglected infectious diseases implies that they may receive low 
priority in terms of resource allocation. It also implies that individuals or social systems that 
have the power to prevent them are constrained by scientific discourses of downstream 
prevention. From the CDA point of view, the construct of NTDs is a reflection of inequalities 
in power. 
<H2>Vector-borne infections 
Table 3 indicates the WHO’s list of major vector-borne diseases and Table 4 shows its list of 
other vector-borne diseases. It is estimated that the major vector-borne diseases together 
account for around 17% of the global burden of communicable diseases, claiming more than 
700 000 lives every year. The evidence shows that the burden is highest in tropical and 
subtropical areas. Morbidity and mortality rates are often disproportionately high in poorer 
populations.[56,57] 
Increased global travel and trade, and social, economic, demographic, and environmental 
factors such as unplanned urbanization and lack of reliable piped water supply or solid waste 
management have all been blamed for the rate, pattern, geographical distribution, and re-
emergence of these diseases. Despite these phenomena occurring in both the economic south 
and north, the disproportionately high burden of VBIs such as malaria, dengue, yellow fever, 
lymphatic filariasis, leishmaniasis, and onchocerciases falls upon areas with a poor health 
infrastructure, underscoring that poverty is a major determinant of the manifestation of 
infectious disease.[30] Furthermore, Brisbois and Ali[58] indicate that the dominant discourse 
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of risk creates disciplinary boundaries which exacerbate the absence of political solutions to 
global climate change. The acceptance that all of the above diseases are linked to factors such 
as climate change creates a discourse where only the scientific community can find solutions 
and all other voices are discredited. 
<H1>Discussion 
The key contribution of this article is that it indicates that institutionalized ways of talking 
about infectious disease create power inequalities between populations where infectious 
disease is endemic and those that benefit from its decline. Consistent with the previous 
research, this study observes that the heaviest burden of infectious disease falls on poor 
populations. However, the difference between this study and others is that it questions the 
current assumption that by producing evidence-based associations between poverty and 
infectious disease we have solved the problem. It challenges the assumptions by dominant 
powers that application of evidence-based practices and guidelines solves the problem of 
infectious disease. It proposes that poverty creates vulnerability to infectious disease and 
restricts access to healthcare and, therefore, biomedical paradigms only serve to shift the 
focus away from the root cause of vulnerability to infectious disease. The current study 
proposes a new hypothesis that the search for the organic causes of infectious diseases needs 
to recognize that poverty is a fundamental determinant of their uneven global burden. This 
hypothesis is consistent with the argument by Molyneux[29] that the focus on organic causes 
of infectious disease has created constructs such as emergence, re-emergence, and neglected 
diseases. This was further validated by the inclusion of the elimination of extreme poverty in 
the MDGs as a way of achieving sustainable reductions in HIV/AIDS, malaria, and TB. 
The finding that most emerging and re-emerging infections are endemic in poor populations 
confirms the WHO’s[54] assertion that even when effective interventions exist, in many low-
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income countries the internal political and economic situation and fragile infrastructure are 
unable to support them.[58,59] The Ebola crisis in West Africa provides a typical example of 
how infectious diseases occur and persist in countries where there are extreme poverty, poor 
or inadequate healthcare systems, conflicts, and high levels of illiteracy. This pattern was also 
observed with other infectious diseases such as TB, poliomyelitis, and HIV. 
There is a general acceptance that measures to achieve sustainable reductions in fundamental 
causes of infectious diseases, as opposed to their outcomes and manifestations, are outside 
the scope of traditional biomedical intervention.[23-25,28,29,60] Farmer[23] explains that despite 
the proven success of biomedical research in discovering cures and treatments for many 
infectious diseases, human pathogens continue to emerge or re-emerge today and have a 
profound impact on populations deprived of social resources.[24] For these reasons, Farmer[23] 
and others have advocated a social determinants approach to the study and prevention of 
infectious diseases at the population level. Farmer promoted wider analytical discourse, but 
did not advocate a “zero-sum game”; for instance, in tackling TB, he advised using effective 
short-term interventions while pursuing the root causes, and being mindful of historical 
contingencies and material changes. He later advocated a new search for understanding, with 
a research agenda and forms of scholarship that can examine the pathogenic effects of social 
inequalities.[61] Marmot argues for a balance of the three pillars, social, economic, and 
environmental, that are vital for health equity.[62] 
The analysis in this paper indicates that social, economic, political, and environmental factors 
all influence the risk of, exposure to, and effects of infectious diseases.[58] For example, the 
poorest populations have the least access to safe drinking water, decent sanitation, and 
effective waste disposal. Therefore, we propose that a sustainable decline in infectious 
disease can only be achieved through improving the socioeconomic status of those at risk. 
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We recommend an integrated three-dimensional model for future research and scholarship. 
This will involve periodic integrated reviews of world literature on infectious disease and 
allow our discourse frameworks to evolve. The three dimensions are: 
• Paradigmatic analysis: This will involve systematic reviews of evidence to assess and 
critique the research stance, discourse vocabulary, ontology, and constraints, with 
reference to the latest paradigms in social justice. 
• Contextual analysis: This will show the sociocultural, institutional, political, and 
economic settings and dynamics that apply to any infectious disease evidence under 
review. It will also include analysis of the research body’s model of study, along with 
its vested interests and affiliations. 
• Synthetic analysis: This will involve periodic critical reviews across all infectious 
diseases in terms of wider determinants and upstream risk factors. 
<H1>Conclusion 
While biotechnological advances—such as improvements in surveillance, early detection, 
vaccination, and antimicrobial drugs—have reduced infectious disease mortality rates, 
particularly in northern economies, the enduring health improvements came from advances 
based on socioeconomic determinants of health. A sustainable reduction in infectious disease 
in the southern countries is most likely to be achieved in the same way. The transient nature 
of infectious diseases means that as soon as we discover solutions to existing diseases, new 
ones take their place because the fundamental determinants remain in place. Poverty prevents 
southern countries from taking full advantage of the biotechnological advances, thus creating 
dependence on the northern countries. 
All this requires a change in the discourse on infectious disease, as it reinforces unequal 
power relations between societies that suffer endemic infectious disease and those who 
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benefit from its decline. We should endeavor to promote a discourse that promotes self-
determination, rather than one that reinforces the hero-victim scenario and power inequalities. 
<H1>Limitations 
The methodology used in this study (CDA) advocates mutual construction of knowledge, so 
the researchers’ understandings and interpretations reflect their perspective (based on their 
experience, values, beliefs, and context) and, therefore, may not be generalized to other 
contexts. In addition, this research extracted and made use of case studies from three 
international organizations which focus on infectious disease, increasing the likelihood of 
bias. 
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Table 1: Emerging infectious diseases/pathogens 
WHO list of top emerging diseases  NIAID EIDs/pathogens: Category A priority 
pathogens 
Crimean Congo hemorrhagic fever Bacillus anthracis (anthrax) 
Ebola virus disease  Clostridium botulinum toxin (botulism) 
Marburg Yersinia pestis (plague) 
Lassa fever  Variola major (smallpox) and other related pox 
viruses 
Middle East Respiratory Syndrome 
(MERS)  
Francisella tularensis (tularemia) 
Severe Acute Respiratory Syndrome Viral hemorrhagic fevers 
Coronavirus diseases Arenaviruses 
Nipah and Rift Valley fever Junin, Machupo, Guanarito, Chapare (new in 
fiscal year (FY) 14), Lassa, Lujo (new in FY 14) 
 Bunyaviruses 
 Hantaviruses causing Hanta Pulmonary 
Syndrome, Rift Valley fever, Crimean Congo 
hemorrhagic fever 
 Flaviviruses 
 Dengue 
 Filoviruses 
 Ebola 
 Marburg 
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Table 2: WHO’s list of neglected tropical diseases  
Dengue Cysticercosis 
Rabies Dracunculiasis (Guinea-worm disease) 
Trachoma Echinococcosis 
Buruli ulcer Foodborne trematode infections 
Endemic treponematoses (including yaws) Lymphatic filariasis (elephantiasis) 
Leprosy Onchocerciasis (river blindness) 
Chagas disease (American trypanosomiasis) Schistosomiasis (bilharziasis) 
Human African trypanosomiasis (sleeping 
sickness) 
Soil-transmitted helminthiases (intestinal 
parasitic worms) 
Leishmaniasis  
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Table 3: WHO’s list of major vector-borne infectious diseases  
Vector Condition High-risk populations 
Anopheles Malaria  Most malaria cases and deaths occur in sub-Saharan 
Africa. However, South-East Asia, Latin America, and 
the Middle East are also at risk  
Aedes Dengue Tropical and sub-tropical climates, Asian, and Latin 
American 
Chikungunya Africa, Asia, and the Indian subcontinent 
Zika virus 
disease 
Africa and Asia, Brazil 
Yellow fever  Endemic in tropical areas of Africa and Central and 
South America 
Culex Japanese 
encephalitis 
South-East Asia and Western Pacific regions 
Lymphatic 
filariasis 
Republic of Congo (DRC), Ethiopia, Indonesia, Nigeria, 
and Zambia are new endemic countries  
Triatomine 
bugs 
Chagas disease Latin America 
Sandflies Leishmaniasis Brazil, Ethiopia, India, Somalia, South Sudan, and Sudan 
Black flies Onchocerciases Angola, Benin, Burkina Faso, Burundi, Cameroon, 
Central African Republic, Chad, Republic of Congo, 
Côte d’Ivoire, Democratic Republic of the Congo, 
Equatorial Guinea, Ethiopia, Gabon, Ghana, Guinea, 
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Guinea-Bissau, Kenya, Liberia, Malawi, Mali, 
Mozambique, Niger, Nigeria, Rwanda, Senegal, Sierra 
Leone, South Sudan, Sudan, Togo, Uganda, United 
Republic of Tanzania 
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Table 4: WHO’s list of other vector-borne infectious diseases  
Vector Condition  High-risk populations 
Aedes Rift Valley fever Republic of Niger 
Culex West Nile fever Africa, Europe, the Middle East, North America, and 
West Asia 
Sandflies Sandfly fever 
(phelebotomus 
fever 
Africa, Europe (particularly the Mediterranean region), 
the Middle East, and Asia (particularly the Indian 
subcontinent) 
Ticks Crimean-Congo 
haemorrhagic 
fever 
Africa, the Balkans, the Middle East, and Asia 
Lyme disease Asia, north-western, central and eastern Europe, and the 
USA 
Relapsing fever 
(borreliosis) 
Western United States, Southern British Columbia, the 
plateau regions of Mexico, Central and South America, 
the Mediterranean, Central Asia, and much of Africa  
Tick-borne 
encephalitis 
Southern part of the non-tropical Eurasian forest belt, 
extending from north-eastern France to the Japanese 
Hokkaido Island  
Tsetse flies Sleeping 
sickness 
(African 
trypanosomiasis) 
Angola, Burkina Faso, Cameroon, Chad, Congo, Côte 
d'Ivoire, Equatorial Guinea, Gabon, Ghana, Guinea, 
Malawi, Nigeria, South Sudan, Uganda, United Republic 
of Tanzania, Zambia, and Zimbabwe 
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Fleas Plague  Madagascar, the Democratic Republic of Congo, and 
Peru. 
Rickettsiosis Bangladesh, Mongolia, Kenya  
Aquatic 
snails 
Schistosomiasis 
(bilharziasis) 
Africa, the Middle East, the Caribbean, Brazil, 
Venezuela, and Suriname 
 
 
